Predicting Treatment Outcomes and Responder Subsets in Scleroderma-related Interstitial Lung Disease

OBJECTIVES: To identify baseline characteristics of patients with Scleroderma-Related Interstitial Lung Disease (SSc-ILD) which predict the most favorable response to a 12-month treatment with oral cyclophosphamide (CYC). METHODS: Regression analyses were retrospectively applied to the Scleroderma L...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roth, Michael D., Tseng, Chi-Hong, Clements, Philip J., Furst, Daniel E., Tashkin, Donald P., Goldin, Jonathan G., Khanna, Dinesh, Kleerup, Eric C., Li, Ning, Elashoff, David, Elashoff, Robert E.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910296/
https://ncbi.nlm.nih.gov/pubmed/21547897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.30438
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires